Qi L - Search Results

1

Pathological Microenvironment-Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes-Hepatic Stellate Cells Malignant Crosstalk.

Zhang LF, Deng WQ, Wang XH, Huang QW, Liang SQ, Ding ZQ, Qi L, Wang Y, Zhou TJ, Xing L, Lee JW, Oh YK, Jiang HL. Zhang LF, et al. Among authors: qi l. Adv Sci (Weinh). 2024 Oct 28:e2408898. doi: 10.1002/advs.202408898. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39467090

2

Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis.

Qi L, Han H, Han MM, Sun Y, Xing L, Jiang HL, Pandol SJ, Li L. Qi L, et al. Biomaterials. 2023 Jan;292:121945. doi: 10.1016/j.biomaterials.2022.121945. Epub 2022 Dec 6. Biomaterials. 2023. PMID: 36508773

3

Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice.

Han MM, He XY, Tang L, Qi L, Yang MY, Wang Y, Xing L, Jeong JH, Jiang HL. Han MM, et al. Among authors: qi l. Sci Adv. 2023 Jul 21;9(29):eadg5358. doi: 10.1126/sciadv.adg5358. Epub 2023 Jul 19. Sci Adv. 2023. PMID: 37467328 Free PMC article.

4

Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling.

Han MM, Tang L, Huang B, Li XN, Fang YF, Qi L, Duan BW, Yao YT, He YJ, Xing L, Jiang HL. Han MM, et al. Among authors: qi l. J Control Release. 2024 Feb;366:732-745. doi: 10.1016/j.jconrel.2024.01.032. Epub 2024 Jan 19. J Control Release. 2024. PMID: 38242209

5

Reactive Oxygen Species-Responsive Nanoparticles Toward Extracellular Matrix Normalization for Pancreatic Fibrosis Regression.

Qi L, Duan BW, Wang H, Liu YJ, Han H, Han MM, Xing L, Jiang HL, Pandol SJ, Li L. Qi L, et al. Adv Sci (Weinh). 2024 May;11(19):e2401254. doi: 10.1002/advs.202401254. Epub 2024 Mar 14. Adv Sci (Weinh). 2024. PMID: 38483920 Free PMC article.

6

Nanomedicine regulating PSC-mediated intercellular crosstalk: Mechanisms and therapeutic strategies.

Wang H, Qi L, Han H, Li X, Han M, Xing L, Li L, Jiang H. Wang H, et al. Among authors: qi l. Acta Pharm Sin B. 2024 Nov;14(11):4756-4775. doi: 10.1016/j.apsb.2024.07.007. Epub 2024 Jul 10. Acta Pharm Sin B. 2024. PMID: 39664424 Free PMC article. Review.

7

Inhibitory Smads suppress pancreatic stellate cell activation through negative feedback in chronic pancreatitis.

Lin H, Dong B, Qi L, Wei Y, Zhang Y, Cai X, Zhang Q, Li J, Li L. Lin H, et al. Among authors: qi l. Ann Transl Med. 2021 Mar;9(5):384. doi: 10.21037/atm-20-4282. Ann Transl Med. 2021. PMID: 33842605 Free PMC article.

8

Identification of Differential Metabolites Between  Type 2 Diabetes and Postchronic Pancreatitis Diabetes (Type 3c) Based on an Untargeted Metabolomics Approach.

Qi L, Ye Z, Lin H. Qi L, et al. Lab Med. 2023 Nov 2;54(6):562-573. doi: 10.1093/labmed/lmad004. Lab Med. 2023. PMID: 36864551

9

Exosomal miR-140-3p and miR-143-3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis.

Zhu X, Liu D, Li G, Zhi M, Sun J, Qi L, Li J, Pandol SJ, Li L. Zhu X, et al. Among authors: qi l. Mol Cell Endocrinol. 2022 Jul 1;551:111653. doi: 10.1016/j.mce.2022.111653. Epub 2022 May 2. Mol Cell Endocrinol. 2022. PMID: 35513284

10

Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What's Known and What's to Know.

Wei Q, Qi L, Lin H, Liu D, Zhu X, Dai Y, Waldron RT, Lugea A, Goodarzi MO, Pandol SJ, Li L. Wei Q, et al. Among authors: qi l. Front Physiol. 2020 Oct 28;11:570276. doi: 10.3389/fphys.2020.570276. eCollection 2020. Front Physiol. 2020. PMID: 33250773 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,757 results

Search Page

Filters